[
  {
    "ts": null,
    "headline": "IBB: Beyond The 2025 Surge, Biotech Breakout",
    "summary": "iShares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.",
    "url": "https://finnhub.io/api/news?id=8d2093e4fbe4954a0995724673d028877e1a938b45a84289884c25a074dc7e55",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769490639,
      "headline": "IBB: Beyond The 2025 Surge, Biotech Breakout",
      "id": 138268876,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233342016/image_2233342016.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "iShares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.",
      "url": "https://finnhub.io/api/news?id=8d2093e4fbe4954a0995724673d028877e1a938b45a84289884c25a074dc7e55"
    }
  }
]